Mark Weinstein

5.1k citations
53 papers · 3.8k indexed · 2 hit papers · h-index 25

Mark Weinstein

53 papers receiving 3.6k citations

Hit Papers

von Willebrand disease (VWD): evid...6301982202619962011250500750

Peers

Mark Weinstein
Comparison fields: 5 of 127
  • Hematology 2.0k
  • Nephrology 454
  • Biochemistry 345
  • Internal Medicine 171
  • Critical Care and Intensive Care Medicine 234
Replace H K Nieuwenhuis with:
H K Nieuwenhuis Netherlands
Elaine M. Sloand United States
Paul Knöbl Austria
Barbara M. Alving United States
PM Mannucci Italy
V. Kiefel Germany
Catherine P.M. Hayward Canada
Miquel Lozano Spain
Lynne Uhl United States
Ri Liesner United Kingdom
Mark Weinstein relative to H K Nieuwenhuis Netherlands H K Nieuwenhuis's profile →
Citations per field
00.5×1.5×2.4×
H K Nieuwenhuis · 1×
Citations per year

Countries citing papers authored by Mark Weinstein

Since Specialization
Citations

This map shows the geographic impact of Mark Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Weinstein more than expected).

Fields of papers citing papers by Mark Weinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Weinstein. The network helps show where Mark Weinstein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Weinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Weinstein Line = papers co-authored together Mark Weinstein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20203
2 201349
3 20111
4 200967
5
von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1breakdown →
2008630
6 199615
7 1995111
8 199596
9 19954
10 199316
11 199237
12 199291
13 19916
14 19903
15 19902
16 198974
17 198626
18 198126
19 197832
20 197115

About Mark Weinstein

Mark Weinstein is a scholar working on Hematology, Genetics and Critical Care and Intensive Care Medicine, having authored 53 papers that have together received 3.8k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (18 papers), Hemophilia Treatment and Research (10 papers), Blood properties and coagulation (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (4 papers). The work is most often cited by research in Hematology (2.0k citations), Nephrology (454 citations) and Biochemistry (345 citations). Mark Weinstein has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Daniel Deykin, Joseph H. Troll, Joel L. Moake, Christine K. Rudy, Suchen L. Hong, José Azócar, Richard H. Seder, E W Salzman, Margaret E. Rick and William L. Nichols. Their work appears in journals such as Haemophilia, British Journal of Haematology, Journal of Clinical Investigation, International Journal of Radiation Oncology*Biology*Physics and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026